This article by Allan May in the September Atlantic illuminates some fundamental problems in the medtech investment environment, which has in the past been one of the most robust industry sectors in Silicon Valley.
Allan is a founder of Life Science Angels, the largest angel organization in the U.S. focused on early stage medical device and life science start-ups. Since 2005, LSA has invested $30M in 30 early stage companies, attracted in excess of $600M in contemporary or follow-on venture capital, and achieved four favorable exits. In 2010, Allan was elected Chairman of the Board of the Kauffman Foundation’s Angel Capital Education Foundation. Allan has founded or invested in over 50 medtech and biotech startups, and lectures frequently on trends and developments affecting early stage biotech and
Leave a Reply